Combination anti-HIV antibody therapy can suppress virus for prolonged period, suggests NIH study - BioPharma-Reporter.com

People with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a study published in the…

While the small study only included 19 participants, the findings offer hope that combination bNAb therapy might offer a future alternative to daily ART for people living with HIV. Shortcomings of a… [+1374 chars]

full article...